Omada Health (OMDA) Q3 FY2026 earnings: revenue $91 million, up 34.2% on the year
Omada Health, Inc. (OMDA) reported revenue of $91 million for Q3 FY2026, the quarter ended 30 September 2026, up 34.2% on the same quarter a year earlier. Net income was $7 million, and diluted earnings per share $0.10. The figures are the company's own, from the 10-Q it filed with the SEC on 6 November 2026.
Revenue
$91 million
+34.2% on the year · +4.0% on the quarter
Q3 FY2024Q3 FY2026
Operating margin
5.3%
-3.7% a year earlier
Q3 FY2024Q3 FY2026
Net income
$7 million
+23.7% on the quarter
Q3 FY2024Q3 FY2026
Diluted EPS
$0.10
+25.0% on the quarter
Q3 FY2024Q3 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 2 raised.
Revenue rose 34% to $91 million: Revenue was $91.3 million for the quarter, against $68.0 million a year earlier. Management said diabetes and hypertension programs led that growth.
Net income turned positive: Net income was $6.6 million, against a net loss of $3.2 million a year earlier.
Total Members reached 1.1 million: Total Members reached 1.1 million, up 36% from a year earlier, after 45% growth reported for the second quarter. Management cited diabetes and hypertension programs and enrollment momentum.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
15.1
4.0
10.1
+277.8%
+49.4%
Capital expenditure
0.1
0.1
0.5
-19.2%
-78.0%
Free cash flow
15.0
3.9
9.6
+289.1%
+56.5%
Free cash flow margin
16.5%
4.4%
14.1%
Cash from investing
-1.6
-1.7
-2.0
Cash from financing
7.9
7.6
-32.7
+4.3%
Depreciation and amortisation
1.7
1.6
1.4
+6.3%
+23.7%
Share-based compensation
5.9
5.6
3.5
+3.9%
+65.5%
Diluted shares, weighted
67m
64m
58m
+5.0%
+16.4%
Shares outstanding at period end
62m
61m
58m
+2.3%
+7.1%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
273
253
217
+8.1%
+25.7%
Redeemable equity
0.0
0.0
0.0
Debt
0.0
0.0
0.0
Other liabilities
75.4
75.5
70.1
-0.1%
+7.5%
Total liabilities and equity
349
328
287
+6.2%
+21.2%
Fixed assets
9.7
9.1
7.5
+7.0%
+29.2%
Goodwill
13.2
13.2
13.2
0.0%
0.0%
Intangible assets
1.1
1.5
2.9
-28.6%
-61.5%
Cash and equivalents
243
222
199
+9.7%
+22.4%
Receivables
48.2
56.6
41.4
-14.8%
+16.3%
Inventory
4.9
4.1
3.1
+18.5%
+55.0%
Other assets
28.2
21.9
20.6
+28.7%
+37.0%
Total assets
349
328
287
+6.2%
+21.2%
Questions
What was Omada Health's revenue in Q3 FY2026?
Omada Health (OMDA) reported revenue of $91 million for Q3 FY2026, the quarter ended 30 September 2026, up 34.2% on the same quarter a year earlier.
How much did Omada Health earn in Q3 FY2026?
Net income for Q3 FY2026 was $7 million, and diluted earnings per share $0.10.
When did Omada Health report Q3 FY2026 results?
Omada Health filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 6 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 6 November 2026: the filing.